[Xinxibao for the treatment of chronic bacterial prostatitis].
OBJECTIVE
To study the effect of Xinxibao as a supplementary drug in the treatment of chronic bacterial prostatitis (CBP).


METHODS
Eighty-one cases of CBP were divided into two groups: Group A (n = 38), treated with Xinxibao combined with sensitive antibiotic, and Group B (n = 43), treated with sensitive antibiotic only. Contrast studies were made on the therapeutic effects in the two groups, and the results were analyzed.


RESULTS
The effectivity rate was significantly higher in Group A than in Group B.


CONCLUSIONS
Xinxibao can effectively relieve the symptoms of CBP.
Liao
Dehuai
D
The Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510260, China. Liaodehuai@yahoo.com.cn
Chen
Zhiguang
Z
Deng
Zhennong
Z
Wang
Donghui
D
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy* / Q000382:microbiology; D015032:Zinc / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D008667:Metalloproteins; D015032:Zinc